Evidence map›Paper›PMID 36673038›Full record

ReviewDiagnostics (Basel, Switzerland)2023

Technological Advancements in Interventional Oncology.

Alessandro Posa, Pierluigi Barbieri, Giulia Mazza, Alessandro Tanzilli, Luigi Natale, Evis Sala, Roberto Iezzi

Abstract readReview
In one paragraph

Review in Diagnostics (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Alessandro PosaDepartment of Diagnostic Imaging, Oncologic Radiotherapy and Hematology-A. Gemelli University Hospital Foundation IRCCS, L.go A. Gemelli 8, 00168 Rome, Italy.ORCID 0000-0001-9617-3413
Pierluigi BarbieriDepartment of Diagnostic Imaging, Oncologic Radiotherapy and Hematology-A. Gemelli University Hospital Foundation IRCCS, L.go A. Gemelli 8, 00168 Rome, Italy.
Giulia MazzaDepartment of Diagnostic Imaging, Oncologic Radiotherapy and Hematology-A. Gemelli University Hospital Foundation IRCCS, L.go A. Gemelli 8, 00168 Rome, Italy.
Alessandro TanzilliDepartment of Diagnostic Imaging, Oncologic Radiotherapy and Hematology-A. Gemelli University Hospital Foundation IRCCS, L.go A. Gemelli 8, 00168 Rome, Italy.ORCID 0000-0002-3331-2831
Luigi NataleDepartment of Diagnostic Imaging, Oncologic Radiotherapy and Hematology-A. Gemelli University Hospital Foundation IRCCS, L.go A. Gemelli 8, 00168 Rome, Italy.ORCID 0000-0002-7949-5119
Evis SalaDepartment of Diagnostic Imaging, Oncologic Radiotherapy and Hematology-A. Gemelli University Hospital Foundation IRCCS, L.go A. Gemelli 8, 00168 Rome, Italy.
Roberto IezziDepartment of Diagnostic Imaging, Oncologic Radiotherapy and Hematology-A. Gemelli University Hospital Foundation IRCCS, L.go A. Gemelli 8, 00168 Rome, Italy.ORCID 0000-0002-2791-481X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Interventional radiology, and particularly interventional oncology, represents one of the medical subspecialties in which technological advancements and innovations play an utterly fundamental role. Artificial intelligence, consisting of big data analysis and feature extrapolation through computational algorithms for disease diagnosis and treatment response evaluation, is nowadays playing an increasingly important role in various healthcare fields and applications, from diagnosis to treatment response prediction. One of the fields which greatly benefits from artificial intelligence is interventional oncology. In addition, digital health, consisting of practical technological applications, can assist healthcare practitioners in their daily activities. This review aims to cover the most useful, established, and interesting artificial intelligence and digital health innovations and updates, to help physicians become more and more involved in their use in clinical practice, particularly in the field of interventional oncology.

Indexed as

artificial intelligenceaugmented realitydigital healthinterventional oncologyinterventional radiologyradiomics

Identifiers

PMID36673038
PMCPMC9857620

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.